Human Epidermal Cells Synthesize HLA-DR Alloantigens In Vitro upon Stimulation with γ-Interferon  by Volc-Platzer, Beatrix et al.
0022-202X/85/8501 -0016$02.00/ 0 
TH E ,JOURNAL OF INV ESTIGATIVE DErtMATOLOGY, 85:16- 19, 1985 
Copyright © 1985 by The Williams & Wilkins Co. 
Vol. 85, No.1 
Printed in U.S.A. 
Human Epidermal Cells Synthesize HLA-DR Alloantigens In Vitro upon 
Stimulation with ')'-Interferon 
BEATRIX VOLC-PLATZER, M.D., HEINZ LEIBL, PH.D., THOMAS LUGER, M.D., GABRIELE ZAHN, PH.D., AND 
GEORG STINGL, M.D. 
Departments of Dermatology I and ll, University of Vienna, Vienna, Austria, and Department of Biochemistry, Thomae G.m.b.H., Biberach, 
F.R.G. 
Under certain pathologic conditions, human kera-
tinocytes synthesize and express HLA-DR antigens. As-
suming that soluble mediators might be responsible for 
this phenomenon, differentiating, primarily DR-
keratinocytes were grown in the presence or absence of 
mixed leukocyte culture supernatants and tested for Ia 
antigen expression. After 6 days of culture, keratino-
cytes displayed surface-bound HLA-DR a/(3 complexes 
when exposed to mixed leukocyte culture supernatants 
but not when cultured in media alone. These HLA-DR 
moieties on keratinocytes result from active biosyn-
thesis as evidenced by the demonstration of the intra-
cytoplasmic HLA-DR 'Y (invariant) chain within these 
cells. In view of reports that interferon-'¥ promotes !a-
production in a variety of cell types, we reasoned that 
this lymphokine might be responsible for the !a-inducing 
property of mixed lymphocyte culture supernatants. In-
deed, recombinant interferon-')', but not interferon-a or 
interleukin-2, proved to be a potent stimulator of Ia 
expression by keratinocytes. The further finding that 
this event can be prevented by the addition of a mono-
clonal anti-interferon-')' antibody strongly suggests that 
this cytokine is directly responsible for HLA-DR pro-
duction by keratinocytes. The interferon--y-induced ac-
quisition of HLA-DR antigens by primarily DR- kerat-
inocytes may provide a useful tool to study the role of 
these alloantigens in T-cell activation and may also add 
to our understanding of mechanisms operative in epi-
dermal cell-T -cell interactions. 
The human major hi stocompatibility complex (MHC) en-
codes for t he production of alloantigens critically needed for 
induction and eli citation of T cell -dependent immune re-
sponses. Whereas class I (HLA-A, -B, -C) alloantigens are 
important restriction elements recognized by cytotoxic T lym-
phocytes, class II (HLA-DR, -DQ, -DP) (1) antigens function 
primarily as restric t ion elements recogn ized by helper/ inducer 
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T lymphocytes [2) . Expression of class II moieties represents 
either a constitutive trait of certain cell populations or, alter-
natively, depends upon the activation state of a given cell type. 
Splenic dendritic cells are a typical example for the former 
situation [3); by contrast, the expression of class II antigens by 
mononuclear phagocytes is greatly influenced by a variety of 
mediators [ 4-6) . 
Within normal human epidermis, Langerhans cells (LC) are 
the only cell types which synthesize and bear class II alloanti-
gens and, although not definitively proven, this property ap-
pears to be a constitutive trait of these cells [7] . Recent evidence 
exists that, under certain pathologic conditions, keratinocytes 
(KC) can synthesize class II alloantigens [8,9). In humans, 
these disease states include cutaneous T-celllymphoma, lichen 
planus, and graft-versus-host disease. It appeared therefore 
quite likely that Ia biosynthesis by KC in skin disease is 
controlled by soluble mediators capable of either inducing or 
inhibiting this event. In the search for the inducer substances 
-y-interferon (IFN--y) appeared to be a good candidate in that 
it has been amply documented that IFN-1' can induce HLA-
DR expression in a wide variety of ontogenetically diverse cell 
types [6,10- 13); in view of the fact. that activated T cells are 
the primary source of this lymphokine [14], and that they are 
abundantly present in the disease states listed, we felt it worth-
while to investigate whether IFN--y or even other T-cell prod-
ucts might induce class II alloantigen expression in primarily 
!a-negative KC. 
MATERIALS AND METHODS 
Cells 
EC were prepared from normal human skin specimens by standard 
trypsinization procedures and grown in tissue culture according to the 
method of Eisinger et al [15]. After confluency had been achieved 
differentiating EC were further propagated in the absence of hydrocot-~ 
tisone. Indirect immunofluorescence (IF) procedures using both anti-
HLA-DR (Becton Dickinson (BD) , Sunnyvale, California) and OKT 6 
(Ortho, Raritan, New Jersey) monoclonal antibodies revealed that the 
confluent EC layers were devoid of cells expressing these antigens. 
Inducer Substances 
Escherichia coli-derived human recombinant IFN --y (Genentech. 
Inc., supplied by Bender & Co. Vienna, Austria) (sp act: 6.8 x 107 U 1 
mg) was used at a concentration of 100 U/ ml culture media. 
E. coli-derived human recombinant IFN-a (Hoffmann-La Roche 
Inc., Nutley, New Jersey) (sp act: 2- 4 X 108 U/mg) was used at a 
working dilution of 360 U/ml cu lture media. 
Recombinant human interleukin-2 (IL-2) was purchased from Am. -
gen Bioi., Thousand Oaks, California, and used at a final dilution of 20 
U/ml culture media. In addition, crude mixed leukocyte cultures-
supernatants (MLC-SN) (dilution 1:4 in culture media) were employed 
for [a-induction experiments. 
Monoclonal Antibodies 
A monoclonal anti-IFN--y antibody (manuscript in preparation) 
which, when used at a concentration of 1 mg/ml, neutralizes at least 
1000 U IFN--y was added to lymphokine-supplemented KC-culture 
media at a concentration of 0.05 and 0.1 mg/ml. Anti-HLA-DR (lgGz..; 
antigenic determinant: HLA-DR a/(3 complex; BD), anti-Leu 10 (lgGl; 
antigenic determinant: HLA-DQ a/(3 complex; BD), and VIC-Y1 (lgG 1 ; 
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antigenic determinant: HLA-DR -y-chain(s)) [16] were employed at 
dilutions ranging from 1:10 to 1:10,000. Normal ascitic fluid and anti-
Leu 1 (BD) reagent served as control. 
fa-Induction Protocol 
EC cultures grown to confluency in minima l essential medium 
(GIBCO, Grand Island, New York) containing 5% fetal bovine serum 
(Flow Labs; Irvine, U.K.), nonessential amino acids, 2 mM L-gluta mine, 
and antibiotic-antimycotic solution (100 U penicillin, 100 U strepto-
mycin, 2.5 mg fungi zone, GIBCO) were supplemented with mediators 
or crude MLC-SN at concentrations as indicated above. In order to 
prevent EC- prostaglandin E2 (PGE.) synthesis, indomethacin (1 X 
10-3 mg/ ml; Sigma Chern., St. Louis, Missouri) was added daily to the 
respective EC cultures. Control cultures were kept without indometh -
acin and with indomethacin in culture media alone. In order to study 
the kinetics of class II alloantigen induction , either the mediator-
supplemented or nonsupplemented cultures were kept for either 1, 3, 
or 6 days. Thereafter, one portion of cultured EC was gently washed in 
media, briefly fixed in 95% methanol at room temperature, and sub-
jected to IF staining procedures. In addition, cultured EC were freed 
and dissociated by applying a trypsin-EDT A solution [15] for 15 min 
at 37•c. After extensive washes, single EC suspension were subjected 
to IF studies and [3H]protein A binding assays. 
Indirect IF 
Single EC (2 x 105) or EC sheets were incubated with 1:10 dilutions 
of anti-HLA-DR, a nti-Leu 10, VIC- Y1, anti-Leu 1, and normal ascitic 
fluid for 30 min at 4 ·c; after phosp hate-buffered saline (PBS) washes, 
the incubation chain was prolonged by using 1:10 diluted fluorescein 
isothiocyanate- labeled goat F(ab)/ a. ntimouse lgG (Tago Inc., Burlin-
game, California) for 30 min at 4oC. After final washes, mounted 
specimens were investigated under a Leitz Ortholux II fluorescent 
microscope. 
Binding Studies 
EC (5 x 105) exposed or nonexposed to the various mediators were 
incubated with 100 Ill of anti-HLA-DR concentrations ranging from 
1:10 to 1:10,000 or with 100 Ill of 1:10 diluted anti -Leu 10 for 20 min 
on ice. After 3 washes with PBS/3% bovine serum albumin (BSA), 300 
Ill of 3H -labeled protein A [17] (Pharmacia, Uppsala, Sweden; approx -
imately 1000 dpm/ lll PBS/BSA) was added to the respective cell pellets 
for anot her 30 min on ice; after final washes cell-bound protein A 
activity was measured in a Beckman LC 6800 liquid scintillation 
counter equipped with a dpm routine. 
RESULTS 
MLC-SN-Mediated fa Expression on Cultured EC 
When EC were cultured in the presence of mitogen-stimu-
lated MLC-SN for 6 days, indirect IF studies demonstrated 
that 20-30% of EC exhibited bright to moderate surface stain-
ing when exposed to anti-HLA-DR, whereas staining with anti-
Leu 10 was barely detectable. Replacement of anti-HLA-DR 
reagent by anti-Leu 1, control ascitic fluid, or media gave 
consistently negative results. In sharp contrast, Ia expression 
by EC was never found when EC were grown in the absence of 
MLC-SN. Although indomethacin alone was not sufficient to 
promote HLA-DR synthesis in EC cultures, the addition of this 
cyclooxygenase inhibitor to cytokine-supplemented media led 
to a significant numerical increa.se of anti-HLA-DR reactive 
cells; thus, all subsequent experiments were conducted in the 
presence of indomethacin. This finding that MLC-SN can 
induce Ia expression by EC was confirmed by ('JH]protein A 
binding studies which revealed significant anti-HLA-DR (at 
least at 0.5-10% concentrations) binding on MLC-SN-treated, 
but not on untreated EC (Fig 1). 
MLC-SN Induce fa Biosynthesis in Cultured EC 
In order to exclude the possibility that surface HLA-DR a/{3 
chain expression by EC might result from passive uptake of 
class II alloantigens possibly deliberated in conventional MLC, 
MLC-SN -treated methanol-fixed epidermal sheets were re-
acted by IF with VIC-Y1 monoclonal antibody directed against 
the cytoplasmic I' (invariant) chain of HLA-DR. Results ob-
:-dlFN 
FIG 1. Epidermal cells (5 X 106) not exposed or exposed to 100 U/ 
ml IFN--y, MLC supernatant (diluted 1:4), 360 U/ml IFN-a, 100 U/ml 
JFN--y + 0.05 mg/ml anti-IFN--y, 100 U/ml IFN --y + 0.1 mg/ml anti-
IFN--y, 20 U/ml IL-2 were incubated with increasing amounts of anti-
HLA-DR (0.01, 0.1, 0.5, 2, 10% anti-HLA-DR) and 1000 dpm/lll 
3H-Iabeled protein A. After final washes the radioactivity of cell -bound 
protein A was measured in a liquid scintillation counter. 
FIG 2. a, Intracytoplasmic demonstration of the HLA-DR invariant 
chain by indirect IF staining in cultured EC afte r exposure to MLC-
SN-containing medium for 6 days. x 160. b, Surface-bound HLA-DR 
a + {3 complexes (visualized by anti-HLA-DR after staining in an 
indirect IF) after 6-day-exposure to IFN--y-containing medium. X 160. 
tained clearly pointed toward the presence of intracytop lasmic 
-y-chain moieties in MLC-SN-treated but not in untreated 
cultured EC monolayers (Fig 2a). 
The Role of MLC-Derived Lymphokines in the Induction of 
HLA-DR Biosynthesis by EC 
In view of the reported efficiency of IFN --y as being the 
major, if not the only, lymphokine capable of either induction 
or enhancement of Ia expression by a variety of ontogenetically 
diverse cell populations [10- 13], we asked whether-within the 
family of MLC-derived lymphokines- IFN--y was also respon-
sible for class II antigen induction in EC. In a first series of 
experiments we found that a 6-day incubat ion of cultured EC 
with recombinant IFN--y (100 U/ml) led to the appearance of 
surface HLA-DR on 55-75 % of cultured EC (Fig 2b) and that 
this event was prevented when the incubation was conducted 
in the presence of a monoclonal anti-IFN--y antibody (Fig 1). 
Accordingly, [3H ]protein A binding studies demonstrated that 
IFN--y was far more effective t han MLC-SN in the induction 
of HLA-DR expression (Fig 1). Studies on the kinetics of HLA-
DR and HLA-DQ upon stimulation with 100 U/ml IFN--y 
revealed the presence of 10- 13% anti-HLA-DR vs 4% of anti-
Leu 10-reactive cells after a 1-day stimulation, whereas, after 
3 days of incubation, the percentage of anti-HLA-DR- and 
anti-Leu 10-reactive cells had increased to 31% and 17%, 
respectively. These results were confirmed when using a [3H] 
protein binding assay (Fig 3). 
The contention that IFN--y is the major, if not only inducer 
of class II alloantigen synthesis by EC was supported by our 
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FIG 3. Epidermal cells (5 x 10'') , exposed to 100 U/ml IFN-')', 
incubated with 10% anti- HLA-DR and 1000 dpm/!11 "H-Iabeled protein 
A after 1, 3, and 6 days of IFN-I' stimu lation. 
furth er findin g t hat both recombinant IFN-a and IL-2 fail ed 
to t ri gge r HLA-DR/ DQ expression on cul tured EC (Fig 1) . 
DISCUSSION 
Wit hin normal huma n epidermis, synt hesis [18] and expres-
s ion of class II a ll oan t igens is restricted to the LC population 
[19 ,20]. Ample evidence ex ists t hat in ce rta in disease states K C 
bear HLA-DR surface moieties [21] and t hat t hese a ntigens 
are synt hes ized by t hese cell s [9]. S ince activated T lympho-
cytes comprise a major po rtion of t he cellula r infiltra te in the 
disease states listed, it appears reasonable to assume t hat t hese 
ce lls- e it he r by means of direct cell contact or, a lternatively, 
by release of so luble mediators- play an induc t ive role in HLA-
DR biosynthesis by KC. T he form er possibility is rather un-
likely due to our previous findin g that, in the a bsence of a 
lymphocytic infil t rate in the epidermis , KC within a ll layers of 
t his tissue uniformly di splay surface-bound HLA -DR antigens 
[9]. In order to test t he latter possibili ty, act ivation ofT cells 
by mitogens a nd/or a lloant ige ns resulting in t he production of 
a plethora of regulato ry lymphok ines [22], appeared a reason-
able in vit ro strategy. Our da ta clearl y demonstrate t hat upon 
stimulation with MLC-S N OR- negative cu ltured EC bear 
HLA-DR a/(3 complexes on t heir surface a nd t hat these moie-
t ies resu lt from active biosynthesis by these ce lls. Al t hough t he 
normal epidermis is composed of ontoge netica ll y di stinct cell 
types, i.e., keratinocytes, melanocytes, Langerhans cell s, and 
Merkel cells, t he cul ture conditions chosen resul t in the selec-
t ive growth a nd differentiation of kerat inocytes [15]. Our con-
te ntion t hat class II a nt ige ns on K C surfaces a re synthes ized 
by t hese ce lls rather t ha n pass ive ly abso rbed from MLC -SN 
containing cul t ure media is der ived from t he intracytoplasmic 
demonstrati on of t he HLA-DR -y cha in , a molecule c ri tica lly 
needed for in tracellular transport of HLA -DR a/(:J chains to 
t he ce ll surface [23]. We t hus conclude t hat primarily HLA-
DR negative KC- in t he presence of MLC-SN- can be stim-
ul ated to synthes ize HLA-DR ant igens. 
ln view of t he reported evidence t hat MLC-SN contain 
d istinct so luble med ia to rs a mong which IFN--y has been shown 
to promote [a production in a variety of ce ll types [6,10-13], 
we directly addressed t he role of t his lymphokine in class II 
a lloantige n induction in KC. Our findin g t hat KC exposed to 
recombinant IFN--y as opposed to recombina nt IFN-a or re-
combina nt IL-2 synthesize a nd express HLA-DR/DQ a nd that 
t his eve nt can be preve nted by t he addi t ion of a monoc lonal 
lFN --y a ntibody strongly suggests t hat this cytokine is directly 
respons ible for c lass 11 a ll oant igen production by K C. 
Although it has been reported t hat t he expression of class II 
products is necessary but not a lone suffic ient to endow a given 
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cell type to initiate !-region-dependent immune functions in T -
cell activation [24], it is also known that the spontaneous loss 
and lymphokine-dependent acquisition of la by macrophages 
directly correlates with t he a ntigen-presenting function of t hese 
cells [25]. This controversy might be based on the fact that 
conventional mac rophage preparations occasionally display a 
certain degree of heterogeneity. The induction of class II moie -
ties on KC-which in their nascent state are uniformly !a-
negative and cannot perform I-region-dependent immune func-
tions- may provide an excellent tool to clarify this issue. Even 
though the functional signifi cance of KC-bound Ia escapes us 
at the present time, the mere demonstration of t his occurrence 
further supports t he contention that EC- T -cell interaction 
functions in a bidirect ional manner. Therefore we assume that 
LC-dependent, EC-triggered T -cell activation may result in the 
delivery of regulatory feedback signals (IFN--y) to KC. This 
event may not only influence the class II antigen expression of 
these ce lls, since IFN--y is a lso known to enhance Fc-IgG 
receptor expression [26], cytokine production [27], and cyto-
toxic effector funct ions of macrophages [28]. Thus it is well 
conceivable that IFN--y exerts a similar effect on K C a nd 
thereby potentiates the role of the epidermis as an immuno-
modulating t issue. 
N ote added in proof: 
During completion of these studies, similar results were obtained by 
other investigators: 
Huff J C, Norris DA, Gary MG, Kissinger RM, Boyce ST, Weston WL: 
Induction of HLA-DR antigens in cultured human keratinocytes 
by stimulated peripheral blood mononuclear cells (abstr) . Clin Res 
32:591A, 1984 
Basham TY, Nickoloff BJ, Merigan TC, Morhenn VB: Recombinant 
gamma interferon induces HLA-DR expression on cu ltured human 
keratinocytes. J Invest Dermatol 83:88- 90, 1984 
REFERENCES 
1. Bodmer J, Bodmer W: Histocompatibili ty 1984. Immunol Today 
51:251- 254, 1984 
2. Schwartz RH: The role of gene products of the major histocompat-
ibili ty complex in T cell activation and cellular interactions, 
Fundamental Immunology. Edited by WE Paul. New York, 
Raven Press, 1984, pp 379- 438 
3. Steinman RM, Nussenzweig MC: Dendritic cells: features and 
functions. Immunol Rev 53:127- 147, 1980 
4. Scher MD, Beller Dl, Unanue ER: Demonstration of a soluble 
mediator that induces exudates rich in Ia+ macrophages. J Exp 
Med 152:1684- 1698, 1980 
5. Steinman RM, Nogueira N, Witmer MD, Tydings JD, Mellman 
IS: Lymphokine enhances the expression and synthesis of Ia 
ant igens on cultured mouse peritoneal macrophages. J Exp Med 
152:1248-1258, 1980 
6. Steeg PS, Moore RN, J ohnson HM, Oppenheim JJ: Regulation of 
murine macrophage Ia antigen expression by a lymphok ine with 
immune interferon activi ty. J Exp Med 156:1780- 1793, 1980 
7. Sting! G, Tamaki K, Katz SI: Origin and function of epidermal 
Langerhans cells. lmmunol Rev 53:149- 174, 1980 
8. Breathnach SM, Katz SI: Keratinocytes synthesize Ia antigen in 
acute cutaneous graft-versus-host disease. J Immunol131:2741-
2743, 1983 
9. Volc-P iatzer B, Majdic 0, Knapp W, Wolff K, Hinterberger W, 
Lechner K, Sting! G: Evidence of HLA-DR biosynthesis by 
human keratinocytes in disease. J Exp Med 159:1784- 1789, 1984 
10. Basham TY, Merigan TC: Recombinant interferon- ')' increases 
HLA-DR synthesis and expression. J lmmunol 130:1492- 1494, 
1983 
11. Pober JS, Gimbrone MA, Cotran RS, Reiss CS, Burakoff SJ, Fiers 
W, Aull KA: Ia expression by vascular endothelium is inducible 
by activated T cells and by human ')'-interferon. J Exp Med 
157:1339-1353, 1983 
12. Kelley VE, Fiers W, Strom TB: Cloned human interferon-')', but 
not in terferon-fi or -a, induces expression of HLA-DR determi -
nants by fetal monocytes and myeloid leukemic cell lines. J 
lmmunol 132:240- 245, 1984 
13. Houghton AN, Thomson TM, Gross D, Oettgen HF, Old LJ: 
Surface antigens of melanoma and melanocytes. Specificity of 
induction of Ia antigen by human ')'- interferon. J Exp Med 
160:255- 269, 1984 
14. Stobo J, Green I, Jackson L, BaronS: Identification of a subpop-
ulation of mouse lymphoid cells required for interferon produc-
July 1985 )' -INTERFERON STIM ULATES H LA-DR ALLOANTIGEN S 19 
t ion afte r stimulation wit h mi togens. J lmmunol 112:1589- 1593, 
1974 
15. Eisinger M, Lee J S, Hefton J M, Drazynkiewicz Z, Chiao JW, de 
Harven E: Human epiderma l ce ll cul tures: growth and di fferen -
tiation in t he absence of derma l components or medium supple-
ments. P roc Nat! Acad Sci USA 76:5340- 5344, 1979 
16. Qua ra nta V, Majdic 0 , Sting! G, Liszka K, Honigsmann H, Knapp 
W: A huma n Ia cytoplasmic determina nt located on mul t iple 
form s of inva rian t chain (-y, -y2, -y3) . J Immunol 132:1900- 1905, 
1984 
17. Rice RM . Means GE: Radioactive labeling of proteins in vit ro. J 
Bioi Chem 246:831- 832, 1971 
18. Morhenn VB, Charron DJ, E nglema n EG : Huma n skin cells syn -
thesize HLA -DR molecules of the same cha rge a nd molecular 
weight as t hose synt hesized by autologous lymphocytes. J Invest 
Dermatol 78: 125- 127, 1982 
19. Rowden G, Lewis MG, Sulliva n AK: Ia ant igen expression on 
human epidermal Langerhans cells. Nature 268:247- 248, 1977 
20. Klareskog L, Tjernlund U, Forsum U, Peterson PA: Epidermal 
Langerhans cells express Ia ant igens. Nature 268:248-250, 1977 
21. Tjernlund U: (J" microglobulin a nd HLA-DR (!a )-antigens in nor-
mal a nd pathological skin. Acta Derm Venereol [Suppl] (Stockh ) 
49:9- 41, 1981 
22. Oppenheim JJ , Luger T , Sztein MB, Steeg P S: Circuit of cytokine-
cell interaction tha t regulates immune and inflammatory reac-
t ions, Self- defense Mecha nisms- Role of Macrophages. Edited 
by D Mizuno, ZA Cohn , K T akeya, N lchida. T okyo, Univ Tokyo 
Press, 1982, pp 127- 136 
23. Kvist S , Wiman K, Claesson L, P eterson PA, Dobberstein B: 
Membrane insertion and oligomeric assembly of H LA-DR his-
tocompat ibili ty ant igens. Cell 29:61- 69, 1982 
24. Va n Voorhis W C, Valinsky J , Hoffm ann E, Luban J , Hair LS, 
Steinman RM: Relative efficacy of huma n monocytes and den-
dri t ic cells as accessory cells for T cell replication . J Exp Med 
158:174- 191, 1983 
25. Beller Dl , Ho K: Regulat ion of macrophage populations. V. Eva l-
uation of the cont rol of macrophage Ia expression in vit ro. J 
Immunol 129:971- 976, 1982. 
26. Perussia B, Dayton ET, Lazarus R, Fanning V, Trinchieri G: 
Immune in terfe ron induces the receptor for monomeric lgG1 on 
human monocytic and myeloid cells. J Exp Med 158:1092- 1113, 
1983 
27. Tweardy DJ , Blades EW, Ellner J J : Concurrent enhancement of 
human monocyte immunoregulato ry and effector functions by 
recombinant in terfe ron --y. Clin Res 32:559A, 1984 
28. Nathan CF, Murray HW, Wiebe ME, Rubin BY: Ident ification of 
in te rfe ron--y as t he lymphokine t hat activates human macro-
phage oxidative metabolism and ant imicrobial activity. J Exp 
Med 158:670-689, 1983 
